Moreover, an in-depth research demonstrated that decreased MEG3 expression may enhance CRC cell proliferation and inhibit apoptosis through upregulation of TGF-β1 and its downstream sphingosine kinase 1 (SPHK1) (Dong et al., 2018). This evidence concerns the gene MEG3 and colorectal carcinoma.